These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 16225353)

  • 1. Methadone for cancer pain: a case report.
    Nixon AJ
    Am J Hosp Palliat Care; 2005; 22(5):337. PubMed ID: 16225353
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful use of methadone in nociceptive cancer pain unresponsive to morphine.
    Leng G; Finnegan MJ
    Palliat Med; 1994; 8(2):153-5. PubMed ID: 7521715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone for cancer pain: what have we learned from clinical studies?
    Soares LG
    Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoclonus associated with high-dose parenteral methadone.
    Ito S; Liao S
    J Palliat Med; 2008 Jul; 11(6):838-41. PubMed ID: 18715174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose ratios between high dose oral morphine or equivalents and oral methadone.
    Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
    J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?
    Zimmermann C; Seccareccia D; Booth CM; Cottrell W
    J Pain Palliat Care Pharmacother; 2005; 19(2):25-31. PubMed ID: 16061458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comments on Ripamonti et al., Pain, 70 (1997) 109-115.
    Morley JS; Makin MK
    Pain; 1997 Oct; 73(1):114-5. PubMed ID: 9414068
    [No Abstract]   [Full Text] [Related]  

  • 11. Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study.
    Rhondali W; Tremellat F; Ledoux M; Ciais JF; Bruera E; Filbet M
    J Palliat Med; 2013 Nov; 16(11):1382-7. PubMed ID: 24116946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral methadone for cancer pain: no indication of Q-T interval prolongation or torsades de pointes.
    Reddy S; Fisch M; Bruera E
    J Pain Symptom Manage; 2004 Oct; 28(4):301-3. PubMed ID: 15471646
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival.
    Ripamonti C; Brunelli C
    J Clin Oncol; 2003 Jul; 21(14):2801-2; author reply 2802-3. PubMed ID: 12860959
    [No Abstract]   [Full Text] [Related]  

  • 14. Conversion from parenteral to oral methadone.
    González-Barboteo J; Porta-Sales J; Sánchez D; Tuca A; Gómez-Batiste X
    J Pain Palliat Care Pharmacother; 2008; 22(3):200-5. PubMed ID: 19042849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain.
    Moksnes K; Kaasa S; Paulsen Ø; Rosland JH; Spigset O; Dale O
    Eur J Clin Pharmacol; 2012 Aug; 68(8):1147-56. PubMed ID: 22374345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone in the treatment of pain and terminal delirum in advanced cancer patients.
    Moryl N; Kogan M; Comfort C; Obbens E
    Palliat Support Care; 2005 Dec; 3(4):311-7. PubMed ID: 17039986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory depression during methadone rotation in a patient with advanced cancer.
    Oneschuk D; Bruera E
    J Palliat Care; 2000; 16(2):50-4. PubMed ID: 10887733
    [No Abstract]   [Full Text] [Related]  

  • 18. Opioid Rotation to Methadone for Refractory Cancer Pain: A Case Series.
    Khoo SY; Aziz FA; Nambbiar P
    J Pain Palliat Care Pharmacother; 2019; 33(3-4):125-130. PubMed ID: 31638444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.
    Lawlor PG; Turner KS; Hanson J; Bruera ED
    Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid rotation from methadone: fraught with difficulties.
    Bhimji K
    J Pain Symptom Manage; 2005 Apr; 29(4):334-5. PubMed ID: 15857735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.